Position in AXGN
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$45,761,243
+$598,786 QoQ
Shares Held
1,381,263
+0.1% QoQ
Ownership
2.60%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Assenagon Asset Management S.A. holds $1,565,807,048 across 30 Medical Devices names. AXGN ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
10,057,936 | $631,135,484 | |
| 2 | ABT |
Abbott Laboratories
|
4,429,571 | $454,784,054 | |
| 3 | DXCM |
Dexcom Inc
|
1,719,249 | $107,968,837 | |
| 4 | EW |
Edwards Lifesciences Corp
|
1,265,714 | $101,358,377 | |
| 5 | PODD |
Insulet Corp
|
257,719 | $54,079,754 | |
| 6 | AXGN |
Axogen, Inc.
This page
|
1,381,263 | $45,761,243 | |
| 7 | BIO |
Bio-Rad Laboratories, Inc.
|
147,834 | $41,208,727 | |
| 8 | IRTC |
iRhythm Holdings, Inc.
|
270,221 | $31,891,482 |
All Filings in AXGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,761,243 | 1,381,263 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $45,162,457 | 1,379,849 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $22,997,044 | 1,289,072 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $11,100,873 | 1,023,122 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $18,522,514 | 1,001,217 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $13,621,313 | 826,536 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $18,381,706 | 1,311,106 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $9,490,271 | 1,310,811 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $500,243 | 61,988 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $423,378 | 61,988 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $309,940 | 61,988 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,546,411 | 278,906 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $3,692,871 | 390,780 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $4,094,823 | 410,303 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $6,153,652 | 516,246 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $4,228,054 | 516,246 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $5,450,810 | 686,500 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $4,794,910 | 511,730 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $6,122,879 | 387,524 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $11,124,330 | 514,777 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $348,228 | 17,188 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $313,697 | 17,525 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $1,065,145 | 91,586 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $2,038,833 | 220,653 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||